The system connected to the scalp of patients, which delivers a constant dosage of electric field or with lower intensity may prolong survival and decreases the growth of death dealing brain tumor, claimed new study from a clinical test led by scientists from the Northwestern Medicine, released in the JAMA journal on 19th December.
Glioblastoma multiform (GBM), the most intense cancer begins within brain, may be overcome with the help of new therapy, which uses the swapping electric currents, known as ‘tumor treating fields or TT Fields that are transferred via a stream of insulated electrodes affixed to a shaved scalp of patient.
Excluding occasional breaks as well as electrode changes by week, the patients connect with the device all the time. Through a cable, the electrodes are connected to a tiny device powered by battery with delivering an electrical field to the brain tissues continuously.
Merging the electric field therapy with a standard chemotherapy lets a notable improvement in progression exiting as well as entire survival of patient with the glioblastoma detected recently.
Dr. Roger Stupp, the leading author of study and neurological surgery professor at the Northwestern University Feinberg School of Medicine, who is also a neuro oncology chief at the neurology department of Northwestern University Feinberg Medicine School, said in a statement that, “This trial establishes a new treatment paradigm that substantially improves the outcome in patients with glioblastoma, and which may have applications in many other forms of cancer.”